Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice

Clinical and Vaccine Immunology

Volumn 16, Issue 5, 2009, Pages 636-645

  Ferreira, D M ^a   Darrieux, M ^a   Silva, D A ^a   Leite, L C C ^a   Ferreira Jr , J M C ^a   Ho, P L ^a   Miyaji, E N ^a   Oliveira, M L S ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTERLEUKIN 17; PNEUMOCOCCAL SURFACE PROTEIN A; PNEUMOCOCCAL SURFACE PROTEIN A5; PNEUMOCOCCAL SURFACE PROTEIN C; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG BINDING; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; LACTOBACILLUS CASEI; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SURVIVAL TIME; TH1 CELL;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CELLS, CULTURED; CYTOKINES; FEMALE; GENETIC VECTORS; LACTOBACILLUS CASEI; LEUKOCYTES, MONONUCLEAR; LUNG; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEUTROPHILS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SEQUENCE ANALYSIS, DNA; SPLEEN; STREPTOCOCCUS PNEUMONIAE; VACCINES, SYNTHETIC; VIRULENCE FACTORS;

EID: 66849111904     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00395-08     Document Type: Article

References (55)

1. Aida, Y., and M. J. Pabst. 1990. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods 132:191-195.
2. Arulanandam, B. P., J. M. Lynch, D. E. Briles, S. Hollingshead, and D. W. Metzger. 2001. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect. Immun. 69: 6718-6724.
3. Audouy, S. A., M. L. van Roosmalen, J. Neef, R. Kanninga, E. Post, M. van Deemter, H. Metselaar, S. van Selm, G. T. Robillard, K. J. Leenhouts, and P. W. Hermans. 2006. Lactococcus lactis GEM particles displaying pneumo- coccal antigens induce local and systemic immune responses following in- tranasal immunization. Vaccine 24:5434-5441.
4. Aujla, S. J., P. J. Dubin, and J. K. Kolls. 2007. Interleukin-17 in pulmonary host defense. Exp. Lung Res. 33:507-518.
5. Aujla, S. J., P. J. Dubin, and J. K. Kolls. 2007. Th17 cells and mucosal hostdefense. Semin. Immunol. 19:377-382.
6. Balachandran, P., A. Brooks-Walter, A. Virolainen-Julkunen, S. K. Holling- shead, and D. E. Briles. 2002. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect. Immun. 70:2526-2534.
7. Basset, A., C. M. Thompson, S. K. Hollingshead, D. E. Briles, E. W. Ades, M.Lipsitch, and R. Malley. 2007. Antibody-independent, CD4+ T-cell-depen- dent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect. Immun. 75:5460-5464.
8. Braconier, J. H., and H. Odeberg. 1982. Granulocyte phagocytosis and killing virulent and avirulent serotypes of Streptococcus pneumoniae. J. Lab. Clin.Med. 100:279-287.
9. Briles, D. E., E. Ades, J. C. Paton, J. S. Sampson, G. M. Carlone, R. C.Huebner, A. Virolainen, E. Swiatlo, and S. K. Hollingshead. 2000. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect. Immun. 68:796-800.
10. Briles, D. E., S. K. Hollingshead, G. S. Nabors, J. C. Paton, and A.Brooks-Walter. 2000. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine 19(Suppl. 1):S87-S95.
11. Campos, I. B., M. Darrieux, D. M. Ferreira, E. N. Miyaji, D. A. Silva, A. P. Areas, K. A. Aires, L. C. Leite, P. L. Ho, and M. L. Oliveira. 2008. Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge. Microbes Infect.10:481-488.
12. Cao, J., D. Chen, W. Xu, T. Chen, S. Xu, J. Luo, Q. Zhao, B. Liu, D. Wang,X. Zhang, Y. Shan, and Y. Yin. 2007. Enhanced protection against pneumo- coccal infection elicited by immunization with the combination of PspA,PspC, and ClpP. Vaccine 25:4996-5005.
13. Cripps, A. W., and J. M. Kyd. 2007. Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: otitis media and acute pneumonia. Vaccine 25:2471-2477.
14. Darrieux,M.,A.T. Moreno,D. M. Ferreira,F. C. Pimenta,A. L. de Andrade, A. P. Lopes, L. C. Leite, and E. N. Miyaji. 2008. Recognition of pneumo- coccal isolates by antisera raised against PspA fragments from different clades. J. Med. Microbiol. 57:273-278.
15. Del Giudice, G., A. Podda, and R. Rappuoli. 2001. What are the limits of adjuvanticity? Vaccine 20(Suppl. 1):S38-S41.
16. Esposito, A. L., C. A. Clark, and W. J. Poirier. 1990. An assessment of the factors contributing to the killing of type 3 Streptococcus pneumoniae by human polymorphonuclear leukocytes in vitro. APMIS 98:111-121.
17. Ferreira, D. M., M. Darrieux, M. L. Oliveira, L. C. Leite, and E. N. Miyaji. 2008. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglob- ulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production. Clin. Vaccine Immunol. 15:499-505.
18. Hanniffy, S. B., A. T. Carter, E. Hitchin, and J. M. Wells. 2007. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J. Infect. Dis. 195:185-193.
19. Kadioglu, A., and P. W. Andrew. 2005. Susceptibility and resistance to pneu- mococcal disease in mice. Brief. Funct. Genomics Proteomics 4:241-247.
20. Kane, M. 1998. Unsafe injections. Bull. W. H. O. 76:99-100.
21. Kemp, K., H. Bruunsgaard, P. Skinhoj, and B. K. Pedersen. 2002. Pneumo- coccal infections in humans are associated with increased apoptosis and trafficking of type 1 cytokine-producing T cells. Infect. Immun. 70:5019-5025.
22. Kerr, A. R., J. J. Irvine, J. J. Search, N. A. Gingles, A. Kadioglu, P. W. Andrew, W. L. McPheat, C. G. Booth, and T. J. Mitchell. 2002. Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect. Immun. 70:1547-1557.
23. Kerr, A. R., L. A. Kirkham, A. Kadioglu, P. W. Andrew, P. Garside, H. Thompson, and T. J. Mitchell. 2005. Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts. Microbes Infect. 7:845-852.
24. Khan, A. Q., Q. Chen, Z. Q. Wu, J. C. Paton, and C. M. Snapper. 2005. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on Toll-like receptor 2. Infect. Immun. 73:298-307.
25. Khan, A. Q., Y. Shen, Z. Q. Wu, T. A. Wynn, and C. M. Snapper. 2002.Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect. Immun. 70:749-761.
26. Kirby, A. C., D. J. Newton, S. R. Carding, and P. M. Kaye. 2007. Pulmonary dendritic cells and alveolar macrophages are regulated by gammadelta T cells during the resolution of S. pneumoniae-induced inflammation. J. Pathol.212:29-37.
27. Lu, Y. J., J. Gross, D. Bogaert, A. Finn, L. Bagrade, Q. Zhang, J. K. Kolls,A. Srivastava, A. Lundgren, S. Forte, C. M. Thompson, K. F. Harney, P. W. Anderson, M. Lipsitch, and R. Malley. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4:e1000159.
28. Malley, R., M. Lipsitch, A. Stack, R. Saladino, G. Fleisher, S. Pelton, C.Thompson, D. Briles, and P. Anderson. 2001. Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect. Immun. 69:4870-4873.
29. Malley, R., A. Srivastava, M. Lipsitch, C. M. Thompson, C. Watkins, A. Tzianabos, and P. W. Anderson. 2006. Antibody-independent, interleukin- 17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect. Immun. 74:2187-2195.
30. Malley, R., K. Trzcinski, A. Srivastava, C. M. Thompson, P. W. Anderson, and M. Lipsitch. 2005. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc. Natl. Acad. Sci. USA 102:4848-4853.
31. McCool, T. L., and J. N. Weiser. 2004. Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization. Infect.Immun. 72:5807-5813.
32. McGeachy, M. J., K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, T. McClanahan, and D. J. Cua. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8:1390-1397.
33. McGeachy, M. J., and D. J. Cua. 2007. T cells doing it for themselves:TGF-beta regulation of Th1 and Th17 cells. Immunity 26:547-549.
34. Mizrachi-Nebenzahl, Y., S. Lifshitz, R. Teitelbaum, S. Novick, A. Levi, D.Benharroch, E. Ling, and R. Dagan. 2003. Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host. Clin. Exp. Immunol. 134:23-31.
35. Mohamadzadeh, M., S. Olson, W. V. Kalina, G. Ruthel, G. L. Demmin, K. L.Warfield, S. Bavari, and T. R. Klaenhammer. 2005. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc.Natl. Acad. Sci. USA 102:2880-2885.
36. Ogunniyi, A. D., M. C. Woodrow, J. T. Poolman, and J. C. Paton. 2001.Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect. Immun. 69:5997-6003.
37. Oliveira, M. L., A. P. Areas, I. B. Campos, V. Monedero, G. Perez-Martinez,E. N. Miyaji, L. C. Leite, K. A. Aires, and P. L. Ho. 2006. Induction of systemic and mucosal immune response and decrease in Streptococcuspneu- moniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect.8:1016-1024.
38. Oliveira, M. L., A. P. Areas, and P. L. Ho. 2007. Intranasal vaccines for protection against respiratory and systemic bacterial infections. Expert Rev.Vaccines 6:419-429.
39. Pasetti, M. F., R. Salerno-Goncalves, and M. B. Sztein. 2005. Mechanisms of adaptive immunity that prevent colonization at mucosal surfaces, p. 35-47. InJ. P. Nataro, P. S. Cohen, H. L. T. Mobley, and J. N. Weiser (ed.), Colonization of mucosal surfaces. ASM Press, Washington, DC.
40. Pimenta, F. C., E. N. Miyaji, A. P. Areas, M. L. Oliveira, A. L. de Andrade, P. L. Ho, S. K. Hollingshead, and L. C. Leite. 2006. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice. Infect. Immun. 74:4939-4944.
41. Priebe, G. P., R. L. Walsh, T. A. Cederroth, A. Kamei, Y. S. Coutinho-Sledge, J. B. Goldberg, and G. B. Pier. 2008. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-het- erologous strains of Pseudomonas aeruginosa. J. Immunol. 181:4965-4975.
42. Racedo, S., J. Villena, M. Medina, G. Aguero, V. Rodriguez, and S. Alvarez. 2006. Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. Microbes Infect. 8:2359-2366.
43. Ramos, C. R., P. A. Abreu, A. L. Nascimento, and P. L. Ho. 2004. Ahigh-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz. J. Med. Biol. Res. 37:1103-1109.
44. Rijneveld, A. W., F. N. Lauw, M. J. Schultz, S. Florquin, A. A. Te Velde, P. Speelman, S. J. Van Deventer, and T. Van Der Poll. 2002. The role of interferon-gamma in murine pneumococcal pneumonia. J. Infect. Dis. 185:91-97.
45. Robinson, K., L. M. Chamberlain, M. C. Lopez, C. M. Rush, H. Marcotte, R. W. Le Page, and J. M. Wells. 2004. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect. Immun. 72:2753-2761.
46. Roche, A. M., S. J. King, and J. N. Weiser. 2007. Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice. Infect. Immun. 75:2469-2475.
47. Schultz, M. J., A. W. Rijneveld, P. Speelman, S. J. van Deventer, and T. van der Poll. 2001. Endogenous interferon-gamma impairs bacterial clearance from lungs during Pseudomonas aeruginosa pneumonia. Eur. Cytok. Netw.12:39-44.
48. Steinman, L. 2007. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13:139-145.
49. Sun, K., F. E. Johansen, L. Eckmann, and D. W. Metzger. 2004. An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage. J. Immunol. 173:4576-4581.
50. Sun, K., S. L. Salmon, S. A. Lotz, and D. W. Metzger. 2007. Interleukin-12promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect. Immun. 75:1196-1202.
51. Tai, S. S. 2006. Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit. Rev. Microbiol. 32:139-153.
52. Trzcinski, K., C. M. Thompson, A. Srivastava, A. Basset, R. Malley, and M. Lipsitch. 2008. Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect. Immun. 76:2678-2684.
53. World Health Organization. 1998. WHO meeting on maternal and neonatal pneumococcal immunization. Wkly. Epidemiol. Rec. 73:187-188.
54. Yamamoto, N., K. Kawakami, Y. Kinjo, K. Miyagi, T. Kinjo, K. Uezu, C. Nakasone, M. Nakamatsu, and A. Saito. 2004. Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae: involvement of inter- feron-gamma. Microbes Infect. 6:1241-1249.
55. Zhang, Q., J. Bernatoniene, L. Bagrade, J. C. Paton, T. J. Mitchell, S.Hammerschmidt, D. A. Nunez, and A. Finn. 2006. Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children. Infect. Immun. 74:4735-4743.